[%uyyK%]
Research by TA
BUY – TP RM38.20

"Remain Sanguine on Medium to Long Term Prospects”

Post MPI’s 4QFY24 investors briefing, we maintain our Buy recommendation, albeit with a lower target price of RM38.20, following the earnings cut to reflect caution regarding the near-term outlook. Despite MPI seeing some slowdown in the automotive segment, the group will continue to adopt an automotive-centric strategy, as management firmly believes that the long-term outlook for the automotive market remains bright. On the other hand, the group will continue to focus on investments related to electric vehicles, silicon carbide and gallium nitride technologies, advanced packaging, 5G testing, and MEMS sensors, among others. 

Analyst:
Chan Mun Chun 
[%CuvZ%]

$KLSE-MPI
Research by TA
BUY – TP RM38.20

"Remain Sanguine on Medium to Long Term Prospects”

Post MPI’s 4QFY24 investors briefing, we maintain our Buy recommendation, albeit with a lower target price of RM38.20, following the earnings cut to reflect caution regarding the near-term outlook. Despite MPI seeing some slowdown in the automotive segment, the group will continue to adopt an automotive-centric strategy, as management firmly believes that the long-term outlook for the automotive market remains bright. On the other hand, the group will continue to focus on investments related to electric vehicles, silicon carbide and gallium nitride technologies, advanced packaging, 5G testing, and MEMS sensors, among others. 

Analyst:
Chan Mun Chun 
mcchan@ta.com.my

$MPI / 3867 (MALAYSIAN PACIFIC INDUSTRIES BERHAD)